- Home
- OXLCP vs BCTXZ Comparison
OXLCP vs BCTXZ Comparison
Compare OXLCP & BCTXZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXLCP
- BCTXZ
- Stock Information
- Founded
- OXLCP N/A
- BCTXZ N/A
- Country
- OXLCP United States
- BCTXZ Canada
- Employees
- OXLCP N/A
- BCTXZ 12
- Industry
- OXLCP Investment Managers
- BCTXZ
- Sector
- OXLCP Finance
- BCTXZ
- Exchange
- OXLCP Nasdaq
- BCTXZ Nasdaq
- Market Cap
- OXLCP N/A
- BCTXZ N/A
- IPO Year
- OXLCP N/A
- BCTXZ N/A
- Fundamental
- Price
- OXLCP $24.21
- BCTXZ $1.06
- Analyst Decision
- OXLCP
- BCTXZ
- Analyst Count
- OXLCP 0
- BCTXZ 0
- Target Price
- OXLCP N/A
- BCTXZ N/A
- AVG Volume (30 Days)
- OXLCP N/A
- BCTXZ N/A
- Earning Date
- OXLCP N/A
- BCTXZ N/A
- Dividend Yield
- OXLCP N/A
- BCTXZ N/A
- EPS Growth
- OXLCP N/A
- BCTXZ N/A
- EPS
- OXLCP N/A
- BCTXZ N/A
- Revenue
- OXLCP N/A
- BCTXZ N/A
- Revenue This Year
- OXLCP N/A
- BCTXZ N/A
- Revenue Next Year
- OXLCP N/A
- BCTXZ N/A
- P/E Ratio
- OXLCP N/A
- BCTXZ N/A
- Revenue Growth
- OXLCP N/A
- BCTXZ N/A
- 52 Week Low
- OXLCP N/A
- BCTXZ N/A
- 52 Week High
- OXLCP N/A
- BCTXZ N/A
- Technical
- Relative Strength Index (RSI)
- OXLCP 46.65
- BCTXZ N/A
- Support Level
- OXLCP $24.18
- BCTXZ N/A
- Resistance Level
- OXLCP $24.34
- BCTXZ N/A
- Average True Range (ATR)
- OXLCP 0.12
- BCTXZ 0.00
- MACD
- OXLCP -0.00
- BCTXZ 0.00
- Stochastic Oscillator
- OXLCP 46.46
- BCTXZ 0.00
About OXLCP Oxford Lane Capital Corp.
Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.
About BCTXZ BriaCell Therapeutics Corp. Warrant
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.